Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study
Sood et al.
Nicotine Tob Res 2009;0:ntp162v2-ntp162.
ABSTRACT
| FULL TEXT
Smoking Cessation: It Is Never Too Late
Nilsson and Fagerstrom
Diabetes Care 2009;32:S423-S425.
FULL TEXT
Why Won't Our Patients Stop Smoking?: The power of nicotine addiction
Mannino
Diabetes Care 2009;32:S426-S428.
FULL TEXT
Secondhand and Prenatal Tobacco Smoke Exposure
Best et al.
Pediatrics 2009;124:e1017-e1044.
ABSTRACT
| FULL TEXT
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database
Gunnell et al.
BMJ 2009;339:b3805-b3805.
ABSTRACT
| FULL TEXT
Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment
Rose et al.
Nicotine Tob Res 2009;11:1067-1075.
ABSTRACT
| FULL TEXT
Treating Tobacco Dependence in a Medical Setting
Hurt et al.
CA Cancer J Clin 2009;59:314-326.
ABSTRACT
| FULL TEXT
Acute Hepatic Injury Associated with Varenicline in a Patient with Underlying Liver Disease
Franck and Sliter
The Annals of Pharmacotherapy 2009;43:1539-1543.
ABSTRACT
| FULL TEXT
Smoking cessation pharmacotherapy
Frishman
Ther Adv Cardiovasc Dis 2009;3:287-308.
ABSTRACT
Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline
Hays et al.
Mayo Clin Proc. 2009;84:730-736.
ABSTRACT
| FULL TEXT
Can smokers switch from a hospital-based to a community-based stop smoking service? An open-label, randomized trial comparing three referral schemes
Lewis et al.
Nicotine Tob Res 2009;11:756-764.
ABSTRACT
| FULL TEXT
Varenicline reduced smoking behaviour in a mentally ill person
Ochoa
J Psychopharmacol 2009;23:340-341.
Combination treatment with varenicline and nicotine replacement therapy
Ebbert et al.
Nicotine Tob Res 2009;11:572-576.
ABSTRACT
| FULL TEXT
Safety and Effectiveness of Varenicline in a Veteran Population with a High Prevalence of Mental Illness
Purvis et al.
The Annals of Pharmacotherapy 2009;43:862-867.
ABSTRACT
| FULL TEXT
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Ellerbeck et al.
ANN INTERN MED 2009;150:437-446.
ABSTRACT
| FULL TEXT
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel
Physiol. Rev. 2009;89:649-705.
ABSTRACT
| FULL TEXT
Macrovascular Complications of Diabetes Mellitus
Nuzum and Merz
Journal of Pharmacy Practice 2009;22:135-148.
ABSTRACT
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence
Ray et al.
J Psychopharmacol 2009;23:168-176.
ABSTRACT
Varenicline and bupropion sustained-release combination therapy for smoking cessation
Ebbert et al.
Nicotine Tob Res 2009;11:234-239.
ABSTRACT
| FULL TEXT
A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
Schroeder
JAMA 2009;301:522-531.
ABSTRACT
| FULL TEXT
Smoking and depression: is smoking cessation effective?
Ischaki and Gratziou
Ther Adv Respir Dis 2009;3:31-38.
ABSTRACT
Moving Forward in Smoking Cessation: Issues for Psychiatric Nurses
Schroeder
J Am Psychiatr Nurses Assoc 2009;15:68-72.
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts
Bader et al.
Tobacco Control 2009;18:34-42.
ABSTRACT
| FULL TEXT
Pharmacological treatments for tobacco dependence
Fagerstrom and Jimenez-Ruiz
ERR 2008;17:192-198.
ABSTRACT
| FULL TEXT
Varenicline for Tobacco Dependence
Hays and Ebbert
NEJM 2008;359:2018-2024.
FULL TEXT
Evidence-based treatments of addiction
O'Brien
Phil Trans R Soc B 2008;363:3277-3286.
ABSTRACT
| FULL TEXT
Review: Pharmacotherapy for smoking cessation
Carrozzi et al.
Ther Adv Respir Dis 2008;2:301-317.
ABSTRACT
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression
Pirmoradi et al.
Am J Health Syst Pharm 2008;65:1624-1626.
ABSTRACT
| FULL TEXT
The place of varenicline in smoking cessation treatment
Aveyard
Thorax 2008;63:666-668.
FULL TEXT
Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi and Salas
Exp. Biol. Med. 2008;233:917-929.
ABSTRACT
| FULL TEXT
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
Aubin et al.
Thorax 2008;63:717-724.
ABSTRACT
| FULL TEXT
Smoking: A Deadly Pleasant Habit--Is There a Way Out?
Richter
ANGIOLOGY 2008;59:49S-53S.
ABSTRACT
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
Eisenberg et al.
CMAJ 2008;179:135-144.
ABSTRACT
| FULL TEXT
Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients
Stein et al.
Circulation 2008;118:e54-e60.
FULL TEXT
Update on pharmacologic and nonpharmacologic therapies for smoking cessation
Schmelzle et al.
cfp 2008;54:994-999.
ABSTRACT
| FULL TEXT
Diffuse exanthema in a patient receiving varenicline
Song and Miller
Am J Health Syst Pharm 2008;65:1239-1241.
ABSTRACT
| FULL TEXT
Positive Modulation of GABAB Receptors Decreased Nicotine Self-Administration and Counteracted Nicotine-Induced Enhancement of Brain Reward Function in Rats
Paterson et al.
J. Pharmacol. Exp. Ther. 2008;326:306-314.
ABSTRACT
| FULL TEXT
{blacktriangledown}Varenicline for smoking cessation
DTB 2008;46:33-36.
ABSTRACT
| FULL TEXT
Drugs (including oxygen) in severe COPD
Albert and Calverley
Eur Respir J 2008;31:1114-1124.
ABSTRACT
| FULL TEXT
Multidisciplinary Care of the Patient with Chronic Obstructive Pulmonary Disease
Kuzma et al.
Proc Am Thorac Soc 2008;5:567-571.
ABSTRACT
| FULL TEXT
How to implement a smoke-free policy
Cormac and McNally
Adv. Psychiatr. Treat. 2008;14:198-207.
ABSTRACT
| FULL TEXT
Differential Role of Nicotinic Acetylcholine Receptor Subunits in Physical and Affective Nicotine Withdrawal Signs
Jackson et al.
J. Pharmacol. Exp. Ther. 2008;325:302-312.
ABSTRACT
| FULL TEXT
Treatment of Tobacco Dependence
Burke et al.
Mayo Clin Proc. 2008;83:479-484.
ABSTRACT
| FULL TEXT
Commentary on "Limb Ischemia: Medical Therapy Trial Update"
Henke
PERSPECT VASC SURG ENDOVASC THER 2008;20:43-44.
Management of Cardiovascular Disease in Renal Transplant Recipients
Shirali and Bia
CJASN 2008;3:491-504.
ABSTRACT
| FULL TEXT
The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline
Hollis et al.
Tobacco Control 2007;16:i53-i59.
ABSTRACT
| FULL TEXT
Pharmacologic Therapy: Novel Approaches for Chronic Obstructive Pulmonary Disease
Bailey and Tashkin
Proc Am Thorac Soc 2007;4:543-548.
ABSTRACT
| FULL TEXT
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary
Rabe et al.
Am. J. Respir. Crit. Care Med. 2007;176:532-555.
ABSTRACT
| FULL TEXT
A Double-blind, Placebo-Controlled, Randomized Trial of Bupropion for Smoking Cessation in Primary Care
Fossati et al.
Arch Intern Med 2007;167:1791-1797.
ABSTRACT
| FULL TEXT
Lung Cancer Chemoprevention: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Gray et al.
Chest 2007;132:56S-68S.
ABSTRACT
| FULL TEXT
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:e1-e157.
FULL TEXT
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
Anderson et al.
J Am Coll Cardiol 2007;50:652-726.
FULL TEXT
Varenicline, an {alpha}4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Steensland et al.
Proc. Natl. Acad. Sci. USA 2007;104:12518-12523.
ABSTRACT
| FULL TEXT
Update in General Internal Medicine
Harrington and Munekata
ANN INTERN MED 2007;147:104-116.
FULL TEXT
Varenicline: The newest agent for smoking cessation
Potts and Garwood
Am J Health Syst Pharm 2007;64:1381-1384.
ABSTRACT
| FULL TEXT
Update in Chronic Obstructive Pulmonary Disease 2006
Rabe et al.
Am. J. Respir. Crit. Care Med. 2007;175:1222-1232.
FULL TEXT
State of the Art Reviews: Smoking Cessation: A Review of Treatment Considerations
Sullivan et al.
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:201-213.
ABSTRACT
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review
Leeman et al.
Alcohol Alcohol 2007;42:196-206.
ABSTRACT
| FULL TEXT
Update in Lung Cancer 2006
Dubey and Powell
Am. J. Respir. Crit. Care Med. 2007;175:868-874.
FULL TEXT
The Year in Atherothrombosis
Sanz et al.
J Am Coll Cardiol 2007;49:1740-1749.
FULL TEXT
Comment: Oral Varenicline for Smoking Cessation
Gonzales et al.
The Annals of Pharmacotherapy 2007;41:720-721.
FULL TEXT
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors
Tapia et al.
Mol. Pharmacol. 2007;71:769-776.
ABSTRACT
| FULL TEXT
Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy
Tonnesen et al.
Eur Respir J 2007;29:390-417.
ABSTRACT
| FULL TEXT
A research agenda for assessing the potential contribution of genomic medicine to tobacco control
Hall
Tobacco Control 2007;16:53-58.
ABSTRACT
| FULL TEXT
Oral Varenicline for Smoking Cessation
Zierler-Brown and Kyle
The Annals of Pharmacotherapy 2007;41:95-99.
ABSTRACT
| FULL TEXT
Efficacy of Varenicline for Smoking Cessation
Dervaux et al.
JAMA 2006;296:2555-2555.
FULL TEXT
Efficacy of Varenicline for Smoking Cessation--Reply
Jorenby et al.
JAMA 2006;296:2555-2556.
FULL TEXT
Trials that Matter: Varenicline: A Designer Drug to Help Smokers Quit.
Schroeder and Sox
ANN INTERN MED 2006;145:784-785.
FULL TEXT
Promising New Drug Could Help Smokers Kick the Habit
Holman
DOC News 2006;3:16-16.
FULL TEXT
Smoking Cessation With Varenicline, a Selective {alpha}4beta2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up.
Nides et al.
Arch Intern Med 2006;166:1561-1568.
ABSTRACT
| FULL TEXT
Is a New Smoking-Cessation Drug on the Horizon?
Journal Watch Cardiology 2006;2006:5-5.
FULL TEXT
New Drug for Smoking Cessation
JWatch General 2006;2006:2-2.
FULL TEXT
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales et al.
JAMA 2006;296:47-55.
ABSTRACT
| FULL TEXT
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad et al.
JAMA 2006;296:64-71.
ABSTRACT
| FULL TEXT
Varenicline for smoking cessation: definite promise, but no panacea.
Klesges et al.
JAMA 2006;296:94-95.
FULL TEXT